Other Lupus News

January 26, 2016

A new study led by scientists at The Scripps Research Institute (TSRI) shows how dangerous autoimmune responses, seen in diseases such as lupus and multiple sclerosis, might be “dialed down” without compromising the immune system’s ability to fight viruses and bacteria.

The new study, published in the journal Proceedings of the National Academy of Sciences, defines an unexpected mechanism at work in an anti-autoimmune drug candidate called ozanimod (now under development by Celgene).                      

January 19, 2016

A recent study showed that enteric-coated mycophenolate sodium (EC-MPS) should be considered as an alternative option to cyclophosphamide (CYC) in the treatment of lupus nephritis (LN).

September 29, 2015

Researchers have released a second set of results from the PROMISSE study showing that proteins measured in the mother’s blood can predict whether or not a woman with lupus is likely to experience serious complications during pregnancy.

September 28, 2015

Newly published study results showed improvement in lupus symptoms with the drug Rituxan® (rituximab), approved to treat rheumatoid arthritis.

September 10, 2015

NIAMS launched a new Spanish-language website that provides free health information on lupus and other conditions of the bones, joints, muscles and skin.

September 8, 2015

newly published study found that perceptions of racism in healthcare were more common in African-American (AA) patients than in white (WH) patients with systemic lupus erythematosus (SLE) and were associated with depression

September 8, 2015

A recently published study has shown an association between high levels of saturated fat in the blood and an increase in inflammatory induced tissue damage.  Published in the September 8 edition of Cell Reports, the study has potential implications for patients with immune disorders such as lupus.

August 31, 2015

Janus Biotherapeutics collaborating with pharmaceutical giant Roche to develop toll-like receptor (TLR) inhibitor with the potential to address several autoimmune diseases – including lupus.